KCC Precedent Search Options

KCC's Corporate Restructuring Court Documents Search provides access to thousands of historical court documents located on KCC public access websites. Please use the form below to refine and maximize search results.

For information about the data provided, please review the Disclaimer statement.


Plan Confirmation and Effective Date:

Please take notice that on April 11, 2020 the Court entered the Findings of Fact, Conclusions of Law, and Order Confirming Modified Amended Joint Chapter 11 Plan of Reorganization of Melinta Therapeutics, Inc. and its Debtor Affiliates [Docket No. 520]. Furthermore, on April 20, 2020, the Debtors filed the Notice of (I) Entry of Findings of Fact, Conclusions of Law and Order Confirming Modified Amended Joint Plan of Reorganization of Melinta Therapeutics, Inc. and its Debtor Affiliates and (II) Occurrence of Effective Date [Docket No. 542].

The Effective Date of the Plan was April 20, 2020.

The Administrative Claims Bar Date was May 20, 2020.

The Deadline to File Rejection Claims for Executory Contracts and Unexpired Leases was May 20, 2020.
General Information:

On December 27, 2019 each of the 6 Debtors filed voluntary petitions for relief under Chapter 11 of the United States Bankruptcy Code (the “Bankruptcy Code”). The cases are jointly administered under Case No. 19-12748 before the Honorable Laurie Selber Silverstein in the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”).

For additional information, please call (866) 556-7696 (U.S./Canada) or (781) 575-2048 (International) or click here to submit an email inquiry.

Important Dates, Deadlines & Documents Show All Dates

January 11, 2021
(2:00 p.m. ET)

June 24, 2020
(5:00 p.m. ET)

April 20, 2020

April 2, 2020
(10:00 a.m. ET)

March 9, 2020
(5:00 p.m. ET)

December 27, 2019

March 30, 2020
(4:00 p.m. ET)

March 13, 2020
(9:30 a.m. ET)

February 6, 2020
(2:00 p.m. ET)

January 28, 2020
(1:30 p.m. ET)

December 30, 2019
(2:00 p.m. ET)

(1) The meeting was continued to a date to be determined.

Meeting of Creditors

The meeting of creditors pursuant to section 341 of the Bankruptcy Code (the "Meeting of Creditors") was held and continued on February 6, 2020 at 2:00 p.m. (ET) at the address listed below. The meeting will be continued on a date to be determined. Please use the following link to view the Notice of Chapter 11 Bankruptcy Case.

J. Caleb Boggs Federal Building
824 Market Street
3rd Floor, Room 3209
Wilmington, DE 19801

Rule 9001(5) of the Federal Rules of Bankruptcy Procedure requires that a representative of the Debtor appear at the Meeting of Creditors for the purpose of being examined under oath by a representative of the Office of the United States Trustee and by any interested parties that attend the meeting. Creditors are welcome, but not required, to attend the meeting. The Meeting of Creditors may be continued or adjourned by notice at the meeting, without further written notice to creditors.


Debtor Name
Debtor Case Number
Melinta Therapeutics, Inc.
Cempra Pharmaceuticals, Inc.
CEM-102 Pharmaceuticals, Inc.
Melinta Subsidiary Corp.
Rempex Pharmaceuticals, Inc.
Targanta Therapeutics Corporation

Parties & Addresses

United States Bankruptcy Court
District of Delaware
824 Market Street North
3rd Floor
Wilmington, DE 19801
T: (302) 252-2900

Melinta Therapeutics Claims Processing Center
c/o KCC
222 N. Pacific Coast Highway, Suite 300
El Segundo, CA 90245
T: (866) 556-7696

Please file proof(s) of claim, if any, via US Mail or other hand delivery system. Facsimile and other electronic delivery methods are not acceptable.  You must file an originally executed proof of claim.  If you would like a copy of your claim returned to you as proof of receipt, please enclose an additional copy and a self-addressed postage-paid envelope.

Attorneys' Addresses

Ron E. Meisler
Christopher M. Dressel
Skadden, Arps, Slate, Meagher & Flom LLP
155 North Wacker Drive
Chicago, IL 60606-1720
T: (312) 407-0700
F: (312) 407-0411

David R. Hurst
McDermott Will & Emery LLP
The Nemours Building
1007 North Orange Street, 4th Floor
Wilmington, DE 19801
T: (202) 756-8950
F: (202) 756-8087